Education
About Us
Working with TipRanks
Follow Us
Vaxil Bio (TSE:VXL)
:VXL
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ 0.00 | C$ 0.00 | C$ -2.00K | C$ -25.00K | C$ -57.00K |
| Operating Income | C$ -196.00K | C$ -254.00K | C$ -584.00K | C$ -986.00K | C$ -1.35M |
| EBITDA | C$ -178.00K | C$ -254.00K | C$ -582.00K | C$ -961.00K | C$ -1.29M |
| Net Income | C$ -178.00K | C$ -254.00 | C$ -584.00K | C$ -986.00K | C$ -1.37M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 714.00K | C$ 938.00K | C$ 1.51M | C$ 2.24M | C$ 1.51M |
| Total Assets | C$ 733.00K | C$ 976.00K | C$ 1.54M | C$ 2.29M | C$ 1.66M |
| Total Debt | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 9.00K |
| Net Debt | C$ -448.00K | C$ -938.00K | C$ -1.51M | C$ -2.24M | C$ -1.50M |
| Total Liabilities | C$ 17.00K | C$ 85.00K | C$ 405.00K | C$ 585.00K | C$ 857.00K |
| Stockholders' Equity | C$ 716.00K | C$ 891.00K | C$ 1.14M | C$ 1.70M | C$ 804.00K |
| Cash Flow | |||||
| Free Cash Flow | C$ -240.00K | C$ -561.00K | C$ -734.00K | C$ -1.08M | C$ -1.10M |
| Operating Cash Flow | C$ -240.00K | C$ -561.00K | C$ -734.00K | C$ -1.08M | C$ -1.10M |
| Investing Cash Flow | C$ -250.00K | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Financing Cash Flow | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 1.81M | C$ 2.56M |
Vaxil Bio Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.